您当前的位置：
首页 >
文章列表页 >
Comparison of efficacy and influential factors between tislelizumab and sintilimab in the treatment of advanced NSCLC
更新时间：2025-12-26

    • Comparison of efficacy and influential factors between tislelizumab and sintilimab in the treatment of advanced NSCLC

    • “The latest research shows that the combination therapy of Trastuzumab and Sindilimab is equally effective and safe in the treatment of advanced non-small cell lung cancer. Age ≥ 60 years and systemic immune inflammatory nutritional index>116.58 are risk factors affecting progression free survival in patients, and the use of antibiotics may affect overall survival.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 24, Pages: 3096-3101(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.24.14    

      CLC： R979.1

    • Received：30 July 2025，

      Revised：2025-09-15，

      Accepted：01 December 2025，

      Published：30 December 2025

    移动端阅览

  • PAN Yan,YANG Shengxi,LIU Jiaxin,et al.Comparison of efficacy and influential factors between tislelizumab and sintilimab in the treatment of advanced NSCLC[J].ZHONGGUO YAOFANG,2025,36(24):3096-3101. DOI： 10.6039/j.issn.1001-0408.2025.24.14.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Active surveillance of drug safety and influential factors in pediatric patients with Mycoplasma pneumoniae pneumonia
Evolutionary game and simulation analysis of add-on payment policy under DRG payment reform in China
Clinical observation of intravitreal injection of ranibizumab in the treatment of macular edema with different OCT subtypes of retinal vein obstruction
Clinical efficacy of donafenib combined with PD-1 inhibitor and vascular intervention therapy in the treatment of unresectable hepatocellular carcinoma
Analysis of clinical characteristics and influential factors of drug-induced liver injury in children caused by intravenous azithromycin

Related Author

WANG Yuefeng
GAO Qiang
QIN Ke
CHEN Ye
LI Jiaming
YANG Fenghong
LI Wei
CHEN Ying

Related Institution

Xinxiang Institute for Food and Drug Control
Dept. of Pharmacy， Xinxiang Central Hospital/the Fourth Clinical College of Henan Medical University
Market Access Policy Research Center， China Pharmaceutical University
School of International Pharmaceutical Business， China Pharmaceutical University
Dept. of Ophthalmology， Xinjiang Production and Construction Corps Hospital
0